Radiotherapy and Oncology

Article	Citations
The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor	138
OC-0088 Reduced tube feeding dependence by continuous improvements in head and neck radiotherapy	106
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)	99
Contents	93
Corrigendum to “DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma p	85
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	79
1861: Performance of a heart substructures autocontouring tool after clinical implementation	79
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	74
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	73
3201: Dosimetric properties of flexible 3D-printed boluses	70
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	68
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	68
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	68
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	68
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	65
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	60
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	59
3429: Modulating innate immunity by DNA damage response inhibition	59
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	59
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	54
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	54
749: Reinforcement learning for accelerated automatic treatment planning optimization	54
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	53
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	52
1635: In vivo dosimetry - keeping my finger on the pulse	49

910: Comparison of Eclipse and RayStation in Multi-Criteria Optimization in Prostate Cancer Radiotherapy	48
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	48
2011: Physical & psychosocial effects of radical chemoradiotherapy for cervix cancer: a systematic review	48
2578: Respiratory gating with CPAP in left breast cancer RT: preliminary results of a prospective study	47
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging	46
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	46
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	46
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	43
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	43
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	43
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	43
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	41
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	40
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	40
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	40
760: Dependence on the calibration field in treatment verifications using the 1600SRS liquid array	39
1977: PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state	38
1006: Prediction of cisplatin tolerance during chemoradiation in older HNSCC patients: A multicenter study	38
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	38
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	38
2116: Outcomes of EBRT and brachytherapy in anal cancer: retrospective analysis between 2016 and 2021	38
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	38
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	38
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	38
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	37
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	37
2010: Postmastectomy radiotherapy after immediate breast reconstruction: toxicities and control rate.	37
2026: Quantitative T1 mapping in the presence of an implantable cardiac device on a 1.5T MR-linac	36
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	35
1537: Brachytherapy efficacy and safety in the treatment of primitive tongue carcinomas	35
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	35
2353: X-irradiation, but not proton, irradiation, induces an inflammatory cytokine response in saliva	34
3484: RAPTOR project: Verification	34
3346: How to balance the patient and clinician needs: Are we on the same side?	34
1136: Electron beam radiotherapy for the management of perianal malignancies	34
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	34
512: Proton minibeam radiation therapy: elucidating in vivo mechanisms with infrared microspectroscopy	33
1651: The impact of ground-glass opacities on dose calculation accuracy for lung SBRT	33
2974: Generalised Competing Risk models predict relative risk of cancer events in p16+ oropharynx cancer	32
3548: Virtual patients for clinical trials	32
1293: Immunotherapy-related hypothyroidism on head and neck cancer: impact of RT dose to the thyroid gland	32
742: EXTREME HYPOFRACTIONATED RT FOR PROSTATE CA. Phase II. Results in toxicity and economical cost	32
2874: Interstitial brachytherapy in carcinoma cervix: long term results, toxicity and patterns of failure	32
3379: Management of older patients with skin cancer: Are we overtreating?	32
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	32
1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data	32
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	32
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	31
692: T1 & T2 mapping on a Unity MRL in a clinically feasible timeframe	31
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	31

994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	30
OC-0449 Deep learning based NTCP-modelling using 3D-information for predicting late xerostomia	30
Response to the Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by Baiocchi et al	30
529 Current standard of care treatment in non-metastatic cervix cancer	29
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	29
A patient-specific auto-planning method for MRI-guided adaptive radiotherapy in prostate cancer	29
Clinical implementation of deep learning robust IMPT planning in oropharyngeal cancer patients: A blinded clinical study	29
Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation	29
Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial	29
480 Addressing the education and training needs of RTT in particle radiation therapy	29
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	28
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	28
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	28
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	28
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	28
525 Proton and carbon therapy: recent technological advances	28
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	28
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	28
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	28
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	27
161 14-day Pathway from Decision to Treat to Radiotherapy for Head and Neck Cancer in the National Health Service: An Evaluation of Feasibility and Outcomes at Torbay Hospital.	27
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	27
179 Contralateral Neck Recurrence Following Unilateral Treatment for Oral Tongue Squamous Cell Carcinoma	27
157 Adaptive radiation therapy	27
45 Stereotactic radiosurgery for tremor: a center experience.	27
123 Can machine-learning model predict overall survival in head and neck cancer patients?	27
78 Targeting tumor-promoting myeloid cell functions in head & neck cancer	27
SP-0510 Physicist: Integration of imaging modalities in treatment planning	26
PO-1053 cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer	26
Radiation therapy for stage IIA/IIB seminomas: Back to the future?	26
SP-0371 Every physicist should also be a fully skilled data scientist	26
95 Head and neck cancers with synchronous primary cancers in Ireland	26
38: Radiation Therapy of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck – Insights from the Analysis of the BC Cancer Registry 2007-2017	26
PO-1061 Acces to radiation therapy in Lebanon: current status and challenges	26
174: Influence of Palliative Radiotherapy on Toxicity and Survival in Patients Treated with Radium-223 Dichloride for Metastatic Castrate-Resistant Prostate Cancer	26
OC-0109 External validation of a prediction model for two-year mortality in esophageal cancer cohorts	25
PO-1835 A glimpse at breast internal mammary chain radiotherapy practice in the United Kingdom	25
MO-0481 Towards near real-time adaptive proton therapy: the partial adaptation strategy	25
PO-1886 Respiratory motion prediction based on LSTM and linear regression models	25
PO-1796 Dosimetric comparison of rectal dose reduction methods in brachytherapy for cervical cancer	25
MO-0148 Time trends for online adapative treatment on the 1.5T MR-Linac	25
OC-0111 Prognostic factors for isolated local recurrence after resection of pancreatic ductal adenocarcinoma	25
MO-0390 Evaluating intra-breath-hold variation in IMAT breast boost patients delivered in DIBH	25
MO-0789 Patient experience of head and neck treatment on a 1.5T MRLinac: is our adaptive solution tolerable?	24
SP-0035 From atlas-based knowledge to ML-based planning solutions	24
SP-0356 Low dose radiotherapy reverses resistance to immunotherapy: From bench to bedside	24
304 the Changing Landscape of Radiation Therapy: Implications for Future Planning	24
12 Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic Tumours	24
33 Efficacy of Ultra Hypofrationed Radiotherapy Combined with HDR Brachytherapy	24
MO-0725 Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology imageS	24
SP-0016 Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma	24
SP-0336 Spatially-fractionated radiotherapy: Tumour-subvolumes, dose-delivery and clinical applications	24
PO-2282 SABR Prostate: A review of specialised techniques for motion management	24
247 the Effect of CT Acquisition Parameters on Extracted Radiomic Features Using Computational Phantoms	23
PO-1406 Re-irradiation in locally recurrent rectal cancer: a national survey of the AIRO GI study group	23
PD-0401 The effect of dose to the brain on early self-reported neurocognition; does low dose matter?	23
PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer	23
261 A 3D Star Shot to Determine Axes of Rotation	23
PD-0398 Clinical outcomes of Thyroid Sparing Radical Chemoradiation in the treatment of Head and Neck cancer	23
133: Interventions to Support Nutrition in Patients Undergoing Concurrent Chemoradiation for Esophageal Cancer: A Systematic Review of Randomized Trials	23
PO-1386 Treatment outcomes of 1.5 T MR-guided adaptive radiotherapy for locally advanced pancreatic cancer	23
MO-0804 Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer	23
PO-1724 Dose-averaged LET may not be the best RBE-descriptor for proton therapy	23
PO-2245 In situ abscopal effect: synergistic efficacy of immunotherapy and partial tumor irradiation	22
PD-0733 Parameters influencing inter-Institute variability in KB plan prediction models for whole breast RT	22
PO-1344 Prognostic significance of platelet-to-lymphocyte ratio in hepatocellular carcinoma	22
PD-0418 Interstitial And Surface Mold Brachytherapy For Head And Neck Cancers- An Institutional Experience	22
PO-2225 Characterization of the RBE of various photon radiation qualities on human cancer cell lines	22
206 Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non-Operative Patients or Salvaging Local Failure	22
PO-1779 Detection of mandibular osteoradionecrosis using novel imaging biomarkers for head and neck cancer	22
PO-1350 Quality of life changes in esophageal cancer patients treated with preoperative or Radical ChemoRT	22
PD-0230 Correlation between External and Internal Tumour Motion in Lung Stereotactic Ablative Radiotherapy	21
OC-0932 Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)	21
PO-1873 Is auto-segmentation in prostate radiotherapy efficient and accurate?	21
PO-1131 Proton and carbon ion therapy for intracranial meningioma after previous brain radiotherapy	21
PD-0805 Inter-observer variation for national Danish contouring atlas on organs at risk in the pelvis	21
OC-0592 Impact of palliative care referral on distress in patients undergoing RT for HNSCC: Randomized Trial	21
OC-0428 Development of DNA polymerase theta inhibitors as tumour specific radiosensitisers	21
PD-0240 Development of mid-treatment biological image guided adaptive radiotherapy (BIGART) for glioblastoma	21
PO-2038 Analysis of daily treatment fractions using PerFRACTION on a Halcyon linac	21

PD-0663 Deep learning cycleGAN MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers	21
OC-0432 Patterns of failure in oral cavity squamous cell carcinoma treated with adjuvant radiotherapy	21
PO-1914 Surface Guided Helical Tomotherapy for Total Marrow Irradiation	21
OC-0594 Head and Neck Squamous Cell Carcinoma derived CAFs alter their phenotype after ionizing radation	21
PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study	21
PO-1893 Gated dynamic trajectory radiotherapy: feasibility, mechanical accuracy and dosimetric validation	21
OC-0426 ALDH genes as regulators of prostate cancer radioresistance, stemness and bone metastases	21
OC-0441 Risk of cardiac death increases with dose to cardiac sub structure avoidance region in lung cancer	21
SP-0013 Weekly contouring rounds and education movies to improve organ at risk delineation in neuro-oncology	21
PO-1938 Organ motion in thorax and abdomen during radiotherapy: a multicenter study in 188 children	21
PO-1694 MRI derived brain morphometric measurements: effect of voxel size, anisotropy and slice orientation	20
PD-0248 Can surface imaging predict the impact of anatomical deformations on proton breast treatment?	20
PO-2130 clinical outcomes of brachytherapy combined with applicator-guided IMRT in bulky cervical tumor	20
PO-1247 Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer	20
126 Investigation of a Monte Carlo Model Based Dose Calculation for 103Pd Low Dose Rate Breast Brachytherapy	20
PO-1685 Creating clinically competitive FLASH proton therapy treatment plans	20
PD-0250 Intrafraction tumor motion monitoring and dose reconstruction for liver spot scanning proton therapy	20
PO-2166 Commissioning of new rectal applicator using electronic brachytherapy source	20
73: Erectile Function After 60 GY in 20 Fractions External Beam Radiotherapy to the Prostate	20
PD-0231 Acute toxicity after the 5-fraction versus 15-fraction radiotherapy regimen for early breast cancer	20
PO-1674 Going from planar kV-MV to kV-kV setup images in image-guided radiotherapy of breast cancer	20
PO-1281 External validation of the MSKCC nomogram for Ductal Carcinoma in Situ and risk factors analysis	20
PD-0654 Surface Guided Radiotherapy accuracy vs tattoos position in 5- fractions breast radiotherapy.	20
109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials	19
PO-1964 Towards a novel treatment plan evaluation concept in carbon ion radiotherapy based on high-LET-dose	19
PD-0253 Ultra-compact and highly efficient proton therapy: Design considerations and clinical simulations	19
PO-1708 Application of dose accumulation for PTV margin design in MR-guided adaptive prostate SBRT	19
SP-0197 Status of brachytherapy education for brachytherapists and future needs in North America	19
MO-0721 Clinicogenomic predictors for the pattern of failure in high-grade glioma	19
OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity	19
PO-1325 Automated rectal tumor segmentation with inter-observer variability-based uncertainty estimates	18
PO-1532 Long-term outcomes of proton beam therapy for elderly patients with prostate cancer	18
PO-1423 PSA dynamics forecasts identify tumor recurrence after external radiotherapy for prostate cancer	18
PO-1468 LATTICE radiotherapy: A one institution experience	18
MO-0881 Evaluation of plan-of-the-day selection in adaptive radiation therapy of cervical cancer	18
SP-1007 For the motion	18
OC-0436 A Delphi consensus study on SBRT for oligometastatic renal cell carcinoma (RCC) an ESTRO ACROP study	18
PO-1421 Is it possible to deliver on-line MR-guided RT for prostate cancer within a feasible time frame?	18
20: Machine Learning Classifier to Reproduce Lung Metastases Tumour Board Decisions	18
MO-0951 Outcome of total body irradiation for hematopoietic stem cell transplantation conditioning	18
SP-1017 What have we learnt and translation to the clinic?	18
OC-0623 First-in-human clinical translation of oxygen-enhanced MRI onto an MR Linac	18
148: Prognostic Factors Influencing Oncologic Outcomes in Merkel Cell Carcinoma: A Retrospective Population-Based Cohort Study	18
OC-0437 Mature outcomes for TROG 99.03: RCT of RT +/- (R)-CVP in Stage I-II Follicular Lymphoma	18
OC-0942 Geometric stability during Stereotactic Arrhythmia Radiotherapy	17
Response to comment on “Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC”	17
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer	17
67: Ensuring Superior Reporting of Non-Inferiority Radiotherapy Clinical Trials: A Systematic Review	17
PO-1488 Local recurrence of prostate cancer after curative RT: the role of salvage SBRT re-irradiation	17
OC-0466 Verification of rectal cancer target auto-contouring by trained RTTs in online adaptive MRIgRT	17
OC-0254 Feasibility of RTT-only Conebeam CT-guided online adaptive radiotherapy for bladder cancer	17
PO-1542 Seminal vesicle displacement with Hydrogel spacer insertion on prostate radiotherapy	17
MO-0384 A CT-radiomics model to predict recurrence post curative-intent radiotherapy for stage I-III NSCLC	17
OC-0933 Automatically Triggered Surface-Based RT in DIBH in Breast Cancer - SAVE HEART dosimetry report	17
PO-1632 deep learning-based automatic segmentation of rectal tumors in endoscopy images	17
PO-1251 Perceived-health status in lung cancer survivors presenting long-term radiotherapy-related fatigue.	17
PO-1670 Initial Assessment of Adaptive Pancreas SBRT Treatment Efficiency using ViewRay MRIdian A3i	17
PO-1533 Determination of field output correction factors for the IBA Razor Diode	17
Contents	17
Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled	17
PO-1652 A new machine learning-based clinical tool for vertebral level verification and treatment planning	17
SP-1034 Oligometastatic renal cell carcinoma	17
SP-1017 Proton arc therapy: Rationale and current status	17
PO-1640 MRI-based deep learning autocontouring: Evaluation and implementation for brain radiotherapy	17
OC-0119 Interactive deep-learning for tumour segmentation in head and neck cancer radiotherapy	17
OC-0592 Patient reported quality of life during and after primary radiotherapy for prostate cancer	17
PO-1530 Dosimetric comparison of Intraoperative Radiotherapy and SRS for liver metastases	17
OC-0122 Deep Learning Segmentation of Cardiac Substructures in Radiotherapy Planning	17
OC-0766 Gain from respiratory gating in left-sided partial breast irradiation in the DBCG PBI trial	16
SP-0524 Prophylactic cranial irradiation in lung cancer: Where are we?	16
394: Dosimetric evaluation of synthetic 3DCTs reconstructed from a single x-ray radiograph using CNN	16
262: Radiation induces Mitochondrial Biogenesis and Cellular Quiescence Exit in PDOX models of pHGG	16
130 head and neck rhabdomyosarcoma; clinicopathological features, trends, and role of adjuvant therapy.	16
Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis	16
PO-1601 GPU accelerated Monte Carlo activation calculations for PET range verification in proton therapy	16
1839: Stimulation of immune response to overcome radioresistance in BRCA1 mutant breast cancer cells	16
2889: Risk Assessment of Patient-Specific Quality Assurance Methods for Particle Therapy	16
230 Body image seen by patients with nasopharyngeal cancer	16
239 Re-irradiation in head and neck cancers: Real-world experience from a tertiary cancer institute	16
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and nec	16
PO-1589 Clinical outcomes of two radiotherapy schedules for spinal cord compression	16
OC-0775 Comprehensive proton dose prediction with Bayesian LSTMs	16
1670: Facing the climate change: is radiotherapy as green as we would? A preliminary analysis	16
527: A novel integrated measure of cervical HDR brachytherapy plan quality	16
94 Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.	16
OC-0267 Long-term results of an SBRT dose-escalation trial for bone and lymph node metastases (NCT03486431)	16
3043: Early response assessment of Ca cervix treated with PETCT based SIB-Online Adaptive Radiotherapy	16
1754 Dose-intensified stereotactic body radiation therapy for vertebral oligometastases: results from a prospective clinical trial	15
244 The volumetric and dosimetric impacts of respiratory motion management in lung SBRT: A systematic review	15
4338 APRT Analysis for Online Adaptive Radiotherapy Contouring and Adaptor Model Evaluations Using Time-Driven Activity-Based Costing	15
4567 Radonek - Fine-Tuned GPT-4o for Radiation Oncology Patient Support: Preliminary Evaluation and Protocol for Prospective Validation	15
4441 Bowel function assessed using Patient Reported Outcome Measures after contact brachytherapy for rectal cancer within the CITRuS trial	15
2418 Bias in radiation therapy publications	15
447 IMRT by Tomotherapy with concurrent weekly cisplatin followed by Brachytherapy HDR in locally advance cervical cancer (prospective study).	15
4411 Hypofractionated radiotherapy for breast cancer after mastectomy : can dosimetric constraints be achieved?	15